Dr Reddy's Laboratories Ltd, a leading pharmaceutical player, witnessed an impressive 11% surge in its consolidated net profit for the third quarter, propelling its shares to an all-time high. The quarter ended December 2023 showcased a net profit of Rs 1,380.9 ...
The outlook for the Indian pharma sector is positive for the year 2024. In the recent quarter, pharmaceutical companies have registered improvement owing to several factors such as improved performance in the US generics market, robust performance in branded markets, moderation ...
Pharma giant Dr Reddy's Laboratories on October 9 released a statement saying that its wholly-owned step-down subsidiary Dr. Reddy's Laboratories, Inc. along with several other pharma companies have been named as defendants in a lawsuit filed on October 6, 2023, in ...
Five leading stocks are scheduled to turn ex-dividend today. These stocks are Control Print Ltd., Pix Transmissions Ltd., Kirloskar Pneumatic Company Ltd., Persistent Systems Ltd., and Dr Reddys Laboratories Ltd. Ex-dividend date is crucial as it decides which shareholder will get ...
Sharekhan has suggested buying the stock of Dr Reddy's for good returns going forward. The firm believes that the stock can achieve a price target of Rs 5550. {photo-feature}...
Mankind Pharma on Wednesday said it has inked a pact with Dr Reddy's Laboratories to acquire two brands -- Combihale and Daffy. While Combihale is used for the treatment of asthma and chronic obstructive pulmonary disease, Daffy is a soap-free moisturising ...
Indian markets continue to be volatile, through the course of the week, even as the US Federal Reserve did not indicate any timeline for tapering. With the markets at near peaks, it is better to also diversify your portfolio into defensive ...
Shares of Dr Reddy's Laboratories soared 10 percent to hit a record high of Rs 5,302.85 after the pharma company informed the settlement of their litigation with Celgene, a wholly-owned subsidiary of Bristol Myers Squibb, relating to patents for REVLIM (lenalidomide) ...
On Thursday, shares of Dr Reddy's Laboratories rose nearly 6 percent to a new all-time high of Rs 4,544 after the company reported a higher than expected profit for the June-ended quarter. The multinational pharma company posted a 12.6 percent ...
On Wednesday, Dr Reddy's Laboratories Ltd reported a 76 percent year-on-year (YoY) jump in the company's net profit for the quarter ended 31 March 2020 at Rs 764.2 crore against Rs 434.4 crore in the same period of the previous year. ...
The benchmark Sensex index is all set for re-constitution from Monday i.e. June 18 with the exit of yet another pharma stock Dr. Reddy's Labs. The stock has been underperforming the sectoral index since the year 2015. Earlier in December, Lupin ...